ClinicalTrials.gg
RecruitingNCT06320925Updated May 29, 2025

SportsPro: Post-Market Clinical Follow Up Study

An observational study in Shoulder Injuries, Knee Injuries and Hip Injuries, sponsored by Stryker Endoscopy. Recruiting at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-29.

Sponsored by Stryker Endoscopy (part of Stryker) · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Dec 2023; still recruiting 2 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
1,500
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 39 studies in Shoulder Injuries with a site in United States — 14 open to participants now, 18 under way, none of them phase 3. Shoulder Injuries · United States.

Planned enrollment
Largest of 13
1,500 · median 59
Started
2023
with 5 others
Observational
13 of 39
7 open now
Primary completion
2026-06
later than 3 of 17 live
Registered
33rd of 39
by date

Among the 39 studies in Shoulder Injuries with a site in United States, this one has the largest planned enrollment of the 13 observational ones that give a count, is one of 6 that started in 2023, is one of 13 observational ones, reaches primary completion later than 3 of the 17 other live ones, and was the 33rd registered.

Shoulder Injuries

118 studies on the registry are indexed under Shoulder Injuries; 32 are open to participants now.

Browse Shoulder Injuries studies →

Open to participants now

14 of the 39 studies in Shoulder Injuries with a site in United States are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 17 Shoulder Injuries studies recruiting now, 8 (47%) set no upper age limit and 6 (35%) stop at 75 or younger; none take children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 39 studies in Shoulder Injuries with a site in United States, or all of them as a file.
02

Study summary

Retrospective, multi-center, chart review (only to include data that is part of the surgeons' standard practice)

Read the detailed description

The purpose of this study is to leverage standard of care data to provide further characterization of clinical outcomes following shoulder, hip and knee joint surgeries.

  • Primary Objective: To describe clinical outcomes of the Stryker Device in the shoulder, hip, and knee joints 6 months after surgical intervention.
  • Secondary Objective: To describe clinical outcomes of the Stryker Device in the shoulder, hip, and knee joints 3 months after surgical intervention.
  • Safety Objective: To describe safety of the Stryker implants in the shoulder, hip, and knee joints 6 months after intervention.
03

Conditions studied

  • Shoulder Injuries
  • Knee Injuries
  • Hip Injuries
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who have undergone a surgical procedure (per indications for use) using the Stryker implants who meet all of the inclusion/exclusion criteria will be screened and enrolled by participating Investigators.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Subject was ≥ 18 years of age at the time of the surgery
  2. Subject has undergone joint space repair using one of the study devices

Exclusion criteria

Exclusion Criteria:

  1. Subjects who are less than 6 months post-intervention
  2. Concurrent participation in an clinical study during the study period
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
1,500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Study Subjects

    Patients who have undergone a surgical procedure (per product indications for use) using the Stryker implants who meet all of the following criteria will be screened and enrolled by participating Investigators.

    Device: Standard of Care Treatment

Interventions

  • DeviceStandard of Care Treatment

    Subject has undergone joint space repair using one of the study devices and meets eligibility criteria

06

What researchers measure

Primary outcomes

  1. ASES

    Change from baseline

    Time frame: 6 months

  2. iHOT-12

    Change from baseline

    Time frame: 6 months

  3. mHHS

    Change from baseline

    Time frame: 6 months

07

Study locations

3 of 3 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2023 (actual). Primary completion is estimated for Jun 2026, 30 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 13, 2024
First posted
Mar 20, 2024
StartActual
Dec 5, 2023
Primary completionEst.
Jun 30, 2026
CompletionEst.
Dec 1, 2026
Last update
May 29, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06320925
Lead sponsor
Stryker Endoscopy
Responsible party
Sponsor
First posted
Mar 20, 2024
Start date
Dec 5, 2023
Primary completion
Jun 30, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
May 29, 2025

Study contacts

Hayley Taylor, MS
Contact
hayley.taylor@stryker.com
8057054206
Colleen Roden, MS
Contact
colleen.roden@stryker.com
9312672041

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion